Key Consolidated Business Indicators
Term |
101st |
102nd |
103rd |
104th |
105th |
Fiscal year ended |
March 2021 |
March 2022 |
March 2023 |
March 2024 |
March 2025 |
Net sales (Millions of yen) |
74,979 |
76,034 |
72,984 |
72,044 |
94,035 |
Operating profit (Millions of yen) |
17,788 |
17,064 |
7,998 |
9,513 |
21,034 |
Profit attributable to owners of the Company (Millions of yen) |
13,405 |
9,549 |
5,440 |
8,025 |
13,945 |
Comprehensive income (Millions of yen) |
16,532 |
9,563 |
5,475 |
11,684 |
14,237 |
Net assets (Millions of yen) |
136,257 |
138,325 |
136,836 |
143,755 |
152,634 |
Total assets (Millions of yen) |
163,332 |
165,181 |
166,328 |
171,623 |
190,422 |
Net assets per share |
(Yen) |
3,555.93 |
3,642.34 |
3,636.17 |
3,796.05 |
3,974.47 |
Profit per share |
(Yen) |
347.37 |
251.43 |
144.80 |
212.67 |
365.42 |
Equity ratio |
(%) |
83.4 |
83.4 |
81.9 |
83.8 |
80.2 |
Return on equity |
(%) |
10.1 |
7.0 |
4.0 |
5.7 |
9.4 |
Price/Earnings ratio |
(Times) |
12.5 |
15.5 |
25.5 |
16.3 |
12.3 |
Cash flow from operating activities (Millions of yen) |
14,380 |
13,336 |
9,253 |
2,577 |
29,780 |
Cash flow from investing activities (Millions of yen) |
(1,644) |
(7,888) |
(2,627) |
(5,854) |
(19,650) |
Cash flow from financing activities (Millions of yen) |
(8,752) |
(8,129) |
(6,990) |
(5,658) |
(5,369) |
Cash and cash equivalents at end of year (Millions of yen) |
77,305 |
74,625 |
74,260 |
65,325 |
70,085 |
Related Data
Term |
101st |
102nd |
103rd |
104th |
105th |
Fiscal year ended |
March 2021 |
March 2022 |
March 2023 |
March 2024 |
March 2025 |
Selling, general and administrative expenses (Millions of yen) |
23,118 |
24,511 |
31,556 |
29,025 |
37,497 |
R&D expenditures (Millions of yen) |
6,736 |
8,420 |
15,789 |
12,543 |
18,725 |
Capital investment in new business and capacity expansion (Millions of yen) |
2,136 |
3,510 |
1,968 |
2,304 |
3,418 |
Depreciation and amortization (Millions of yen) |
2,318 |
2,481 |
2,546 |
2,596 |
2,475 |